Water Tower Research's Thierry Wuilloud joined Proactive to discuss XpresSpa Group's successful airport-based COVID testing business, and how he sees this continuing as outbound international passenger testing becomes a standard element of international travel.
Wuilloud says as the only national health provider in US airports, XpresSpa Group is in a position to build on this business with additional contracts with airlines and airports as well as biosurveillance assignments with the CDC and other governmental entities. He adds the traditional spa business is expected to return, having generated $45M in annual revenues pre-COVID.